Centralization of Corruption
The discussion reveals how Big Pharma has shifted its strategy from direct marketing to healthcare professionals to a more centralized approach, focusing on influencing high-level decision-makers. By securing endorsements from regulatory bodies and health ministries, they can efficiently control prescriptions on a massive scale. This new model highlights a concerning fusion of public and private interests, raising questions about accountability and the implications for patient safety.In this clip
From this podcast
Doc Malik
#294 - Alex Kriel: Power, Politics, and Truth
Related Questions